4
Shared Docs
4
Same-Page
4 / 4
Mentions
Square Place, Suite 520 September 18, 2020 Anders Franzon General Counsel MEMX LLC 111 Town Square Place, Suite 520 Jersey City, NJ 07310 Dear Mr. Franzon: In your letter dated September 18, 2020,1 you request assurance that the Staff will not recommend enforcement action to the Commission under paragr
eadership capacities leading high- technology medical device companies. In 2008, he was the President and Chief Executive Officer for Nellix Inc. in Palo Alto California, a privately held medical device company specializing in the endovascular treatment of Abdominal Aortic Aneurysms. wesupergreen.com The SEC revoke
Square Place, Suite 520 September 18, 2020 Anders Franzon General Counsel MEMX LLC 111 Town Square Place, Suite 520 Jersey City, NJ 07310 Dear Mr. Franzon: In your letter dated September 18, 2020,1 you request assurance that the Staff will not recommend enforcement action to the Commission under paragr
eadership capacities leading high- technology medical device companies. In 2008, he was the President and Chief Executive Officer for Nellix Inc. in Palo Alto California, a privately held medical device company specializing in the endovascular treatment of Abdominal Aortic Aneurysms. wesupergreen.com The SEC revoke
Square Place, Suite 520 September 18, 2020 Anders Franzon General Counsel MEMX LLC 111 Town Square Place, Suite 520 Jersey City, NJ 07310 Dear Mr. Franzon: In your letter dated September 18, 2020,1 you request assurance that the Staff will not recommend enforcement action to the Commission under paragr
eadership capacities leading high- technology medical device companies. In 2008, he was the President and Chief Executive Officer for Nellix Inc. in Palo Alto California, a privately held medical device company specializing in the endovascular treatment of Abdominal Aortic Aneurysms. wesupergreen.com The SEC revoke
Square Place, Suite 520 September 18, 2020 Anders Franzon General Counsel MEMX LLC 111 Town Square Place, Suite 520 Jersey City, NJ 07310 Dear Mr. Franzon: In your letter dated September 18, 2020,1 you request assurance that the Staff will not recommend enforcement action to the Commission under paragr
eadership capacities leading high- technology medical device companies. In 2008, he was the President and Chief Executive Officer for Nellix Inc. in Palo Alto California, a privately held medical device company specializing in the endovascular treatment of Abdominal Aortic Aneurysms. wesupergreen.com The SEC revoke
Entities connected to both Franzon and Palo Alto California
Chris Dilorio
PERSONGensler
PERSON
Supreme Court
ORGANIZATION
George Mitchell
PERSONSupergreen
ORGANIZATIONSupergreen Energy Corp
ORGANIZATIONPeizer
PERSONCosta Mesa
LOCATIONSocius
PERSONthe Stem Cell Therapy
ORGANIZATIONElectric Power Monthly - U.S. Energy Information Administration
ORGANIZATIONStem Cell Therapy
PERSONDavid Reichman
PERSONCalvin Cao
PERSONGLOBE NEWSWIRE
ORGANIZATION
Samantha Power
PERSONFka GoHealth MD
PERSONWadhwa
PERSON
Jared Kushner
PERSONCasetext
ORGANIZATION